Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
SAR-442501 by Sanofi for Achondroplasia: Likelihood of Approval
SAR-442501 is under clinical development by Sanofi and currently in Phase I for Achondroplasia. According to GlobalData, Phase I drugs...